Correlation between Compartmental Tenofovir Concentrations and an Ex Vivo Rectal Biopsy Model of Tissue Infectibility in the RMP-02/MTN-006 Phase 1 Study-Reference-Cited by-同舟云学术

Correlation between Compartmental Tenofovir Concentrations and an Ex Vivo Rectal Biopsy Model of Tissue Infectibility in the RMP-02/MTN-006 Phase 1 Study

Published:2014-10-28 Issue:10 Volume:9 Page:e111507
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Richardson-Harman Nicola,Hendrix Craig W.,Bumpus Namandjé N.,Mauck Christine,Cranston Ross D.,Yang Kuo,Elliott Julie,Tanner Karen,McGowan Ian,Kashuba Angela,Anton Peter A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference17 articles.

1. A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection;SR Abner;J Infect Dis,2005

2. HIV infection of human fetal intestinal explant cultures induces epithelial cell proliferation;PA Batman;AIDS,1994

3. HIV-1 infection of human penile explant tissue and protection by candidate microbicides;L Fischetti;AIDS,2009

4. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides;P Greenhead;J Virol,2000

5. Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities;F Hladik;Antiviral Res,2010

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-clinical evaluation of antiproteases as potential candidates for HIV-1 pre-exposure prophylaxis;Frontiers in Reproductive Health;2022-11-21

2. Mucosal Responses to Zika Virus Infection in Cynomolgus Macaques;Pathogens;2022-09-12

3. Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue;Pharmaceutics;2022-06-16

4. The ex vivo pharmacology of HIV-1 antiretrovirals differs between macaques and humans;iScience;2022-06

5. Ex Vivo Evaluation of Mucosal Responses to Vaccination with ALVAC and AIDSVAX of Non-Human Primates;Vaccines;2022-01-25